Insider · CIK 0001527192
Kelly Hefner Barrett
director
Files at LPX (LOUISIANA-PACIFIC CORP), PDM (Piedmont Office Realty Trust, Inc.), COLD (AMERICOLD REALTY TRUST), EVTC (EVERTEC, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 22, 2025 | EVTC EVERTEC, Inc. | AGrant or award Common Stock | +4,113 | $37.07 | $152k | 18,562 | Jun 3, 2025 |
| May 20, 2025 | COLD AMERICOLD REALTY TRUST | MOption exercise Common Stock | +6,917 | $0.00 | $0 | 32,892 | May 22, 2025 |
| May 20, 2025 | COLD AMERICOLD REALTY TRUST | MOption exercise Restricted Stock Unitsderivative | -6,917 | $0.00 | $0 | 0 | May 22, 2025 |
| May 20, 2025 | COLD AMERICOLD REALTY TRUST | AGrant or award Restricted Stock Unitsderivative | +10,124 | $0.00 | $0 | 10,124 | May 22, 2025 |
| May 15, 2025 | LPX LOUISIANA-PACIFIC CORP | AGrant or award Common Stock | +1,499 | $0.00 | $0 | 1,789 | May 19, 2025 |
| May 15, 2025 | PDM Piedmont Office Realty Trust, Inc. | AGrant or award Restricted Stock Unitsderivative | +15,217 | $0.00 | $0 | 15,217 | May 16, 2025 |
| May 7, 2025 | PDM Piedmont Office Realty Trust, Inc. | MOption exercise Common Stock | +14,388 | $0.00 | $0 | 82,209 | May 8, 2025 |
| May 7, 2025 | PDM Piedmont Office Realty Trust, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,388 | $0.00 | $0 | 0 | May 8, 2025 |
| Mar 4, 2025 | LPX LOUISIANA-PACIFIC CORP | AGrant or award Common Stock | +290 | $0.00 | $0 | 290 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.